{ "items": [ "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n B-cell receptor repertoire sequencing in patients with primary immunodeficiency: a review.\n

\n \n \n \n \n\n \n \n \n

Ghraichy M. et al, (2018), Immunology, 153, 145 - 160

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Structurally Mapping Antibody Repertoires.\n

\n \n \n \n \n\n \n \n \n

Krawczyk K. et al, (2018), Front Immunol, 9

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Subclinical meningoventriculitis as a cause of obstructive hydrocephalus.\n

\n \n \n \n \n\n \n \n \n

Visagan R. et al, (2017), BMJ Case Rep, 2017

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n The Influence of Maternally Derived Antibody and Infant Age at Vaccination on Infant Vaccine Responses : An Individual Participant Meta-analysis.\n

\n \n \n \n \n\n \n \n \n

Voysey M. et al, (2017), JAMA Pediatr, 171, 637 - 646

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Memory B cell response to a PCV-13 booster in 3.5year old children primed with either PCV-7 or PCV-13.\n

\n \n \n \n \n\n \n \n \n

Tr\u00fcck J. et al, (2017), Vaccine, 35, 2701 - 2708

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Divergent Memory B Cell Responses in a Mixed Infant Pneumococcal Conjugate Vaccine Schedule.\n

\n \n \n \n \n\n \n \n \n

Tr\u00fcck J. et al, (2017), Pediatr Infect Dis J, 36, e130 - e135

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Fifteen-minute consultation: enterovirus meningitis and encephalitis-when can we stop the antibiotics?\n

\n \n \n \n \n\n \n \n \n

Drysdale SB. and Kelly DF., (2017), Arch Dis Child Educ Pract Ed, 102, 66 - 71

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Age-specific trends in antibiotic resistance in Escherichia coli infections in Oxford, United Kingdom 2013-2014.\n

\n \n \n \n \n\n \n \n \n

Robey RC. et al, (2017), J Infect, 74, 195 - 198

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine.\n

\n \n \n \n \n\n \n \n \n

O'Connor D. et al, (2017), Genome Med, 9

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n How B-Cell Receptor Repertoire Sequencing Can Be Enriched with Structural Antibody Data.\n

\n \n \n \n \n\n \n \n \n

Kovaltsuk A. et al, (2017), Front Immunol, 8

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n The Antibody-Secreting Cell Response to Infection: Kinetics and Clinical Applications.\n

\n \n \n \n \n\n \n \n \n

Carter MJ. et al, (2017), Front Immunol, 8

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Variable phenotype and discrete alterations of immune phenotypes in CTP synthase 1 deficiency: Report of 2 siblings.\n

\n \n \n \n \n\n \n \n \n

Tr\u00fcck J. et al, (2016), J Allergy Clin Immunol, 138, 1722 - 1725.e6

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Investigating the effect of AS03 adjuvant on the plasma cell repertoire following pH1N1 influenza vaccination.\n

\n \n \n \n \n\n \n \n \n

Galson JD. et al, (2016), Sci Rep, 6

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Erratum to: B-cell repertoire dynamics after sequential hepatitis B vaccination and evidence for cross-reactive B-cell activation.\n

\n \n \n \n \n\n \n \n \n

Galson JD. et al, (2016), Genome Med, 8

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n B-cell repertoire dynamics after sequential hepatitis B vaccination and evidence for cross-reactive B-cell activation.\n

\n \n \n \n \n\n \n \n \n

Galson JD. et al, (2016), Genome Med, 8

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Sex-dependent immune responses to infant vaccination: an individual participant data meta-analysis of antibody and memory B cells.\n

\n \n \n \n \n\n \n \n \n

Voysey M. et al, (2016), Vaccine, 34, 1657 - 1664

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Analysis of B Cell Repertoire Dynamics Following Hepatitis B Vaccination in Humans, and Enrichment of Vaccine-specific Antibody Sequences.\n

\n \n \n \n \n\n \n \n \n

Galson JD. et al, (2015), EBioMedicine, 2, 2070 - 2079

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n BCR repertoire sequencing: different patterns of B-cell activation after two Meningococcal vaccines.\n

\n \n \n \n \n\n \n \n \n

Galson JD. et al, (2015), Immunol Cell Biol, 93, 885 - 895

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n BCR repertoire sequencing: Different patterns of B-cell activation after two Meningococcal vaccines\n

\n \n \n \n \n\n \n \n \n

Galson JD. et al, (2015), Immunology and Cell Biology, 93, 885 - 895

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Management and outcome of encephalitis in children\n

\n \n \n \n \n\n \n \n \n

Iro MA. and Kelly DF., (2015), Paediatrics and Child Health (United Kingdom), 25, 490 - 497

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n" ], "more": "\n\n \n \n Load More\n \n \n\n", "msg": "" }